Table 1.
Characteristic | Group; No. (%) of Patients* | |
---|---|---|
| ||
Baseline (n = 38) | Pilot Study (n = 46) | |
Age (median and range) | 9.0 mo (1 d to 17 yr) | 5.9 mo (3 d to 16 yr) |
| ||
Sex, male | 26 (68) | 28 (61) |
| ||
Medical condition | ||
Congenital heart defect: single ventricle | 5 (13) | 13 (28) |
Congenital heart defect: non–single ventricle | 26 (68) | 25 (54) |
Heart failure (cardiomyopathy) | 3 (8) | 5 (11) |
Other† | 4 (11) | 3 (7) |
| ||
Total no. of home medications | ||
0‡ | 7 (18) | 3 (7) |
1 | 6 (16) | 7 (15) |
2 | 7 (18) | 7 (15) |
3 | 7 (18) | 5 (11) |
>3‡ | 11 (29) | 24 (52) |
| ||
No. of home medications per patient (median and range) | ||
Prescription | 1.5 (0–8) | 2.5(0–15) |
Nonprescription | 1.0 (0–4) | 0 (0–5) |
Except where indicated otherwise.
Arrhythmia, infection, seizures, hyponatremia, hypercholesterolemia, pulmonary hypertension.
Significant difference, p < 0.05.